![Metame health](/api/images/company-pic/0-1246010-company.png)
Contact us
About company
MetaMe Health is currently developing Regulora™ for IBS to become the first FDA-cleared prescription-only digital therapeutic for the treatment of Irritable Bowel Syndrome (IBS). More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora™ for IBS provides relief by digitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms.
US
Unknown
Not verified company
Business transparency
- Did not verified company info
- Ask their customers for reviews
- Did not replied to negative reviews